Previous Chapter Chapter 57: Japanese Markets for Orthopedic Biomaterials Next Chapter

  • Citations
  • Add to My List
  • Text Size

Japanese Markets for Orthopedic Biomaterials
Japanese markets for orthopedic biomaterials
Millennium Research Group, A Decision Resources, Inc. Company

The Japanese orthopedic biomaterials market is composed of bone graft substitutes (BGS) and hyaluronic acid (HA) injections for viscosupplementation. In 2005, this market generated in excess of $440 million in revenues. Over the forecast period, driven in large part by an aging population, both segments of this market will present growth. For BGS specifically, growth will also be facilitated by increasing surgeon familiarity with BGS and next-generation products. HA market growth will be facilitated by high patient acceptance, as well as expanding indications for viscosupplementation. Limiting growth in both segments will be biennial reimbursement cuts, forcing product distributors to lower their prices, which will result in lower average selling ...

Looks like you do not have access to this content.


Don’t know how to login?

Click here for free trial login.

Back to Top

Copy and paste the following HTML into your website